hepatocellular-carcinoma

Documents about hepatocellular-carcinoma

• Comparison of Atezolizumab/Bevacizumab Versus Durvalumab/Tremelimumab (STRIDE) Protocols in Locally Advanced or Metastatic Hepatocellular Carcinoma Among Patients in Sohag#424177ClinicalTrials.gov
• Icaritin Soft Capsule Versus Huachansu Tablet in the First-line Treatment of Unresectable Hepatocellular Carcinoma With Poor Conditions and Biomarker Enrichment (Biomarker Enrichment Study of Poor Prognosis HCC Patients, BESTPOP)#895521ClinicalTrials.gov
• Prospective Observational Trial to Evaluate Quality of Life After Stereotactic Ablative Radiation Therapy in Patients With Hepatocellular Carcinoma#849181ClinicalTrials.gov
• Interventional Study of INCB 99280 With Ipilimumab in Participants With Select Solid Tumors#871114ClinicalTrials.gov
• Artificial Intelligence in Hepatocellular Carcinoma: Current Applications, Clinical Performance, and Barriers to Implementation.#12801NCBI PubMed Central
• Machine learning for Improving Risk Stratification of Hepatocellular Carcinoma (HCC) Patients Treated with Immune Checkpoint Inhibitors (ICIs)#13290DataCite
• Dual-Target GPC3/B7-H3 CAR-NK Cells for Advanced HCC#67884ClinicalTrials.gov
• CAR-T Cell Immunotherapy for HCC Targeting GPC3#123465ClinicalTrials.gov
• CXCR4-Targeted Nanotherapeutics: A Promising Approach for Liver Fibrosis and Hepatocellular Carcinoma Management.#135921NCBI PubMed Central
• Personalized DC Vaccine for Postoperative Cancer#141079ClinicalTrials.gov
• HR Versus RFA for HCC in Patients With PHT#141115ClinicalTrials.gov
• Preoperative Prediction of TACE Refractoriness in Hepatocellular Carcinoma Using CT-Based Radiomics Model.#170654NCBI PubMed Central
• Current advances and future directions in the management of HBV-related hepatocellular carcinoma.#281004NCBI PubMed Central
• Ferroptosis regulatory networks as therapeutic sensitizers in combination therapy for hepatocellular carcinoma (Review).#412223NCBI PubMed Central
• Incidental Detection of Hepatocellular Carcinoma by Echocardiographic Imaging During Acute Coronary Syndrome Evaluation.#427964NCBI PubMed Central
• ICIs With and Without MWA in Advanced Hepatocellular Carcinoma#668809ClinicalTrials.gov
• MR Quality + Diagnostic Performance for CHC Diagnosis - Gadoxetic Acid, Gadoteric Acid and P03277 Comparison#802287ClinicalTrials.gov
• A Trial of SHR-1210 in Combination With Apatinib in Patients With Unresectable HCC#807338ClinicalTrials.gov
• Cryoablation Combined With Tislelizumab Plus Lenvatinib in 1L Treatment of Advanced HCC (CASTLE-10)#813765ClinicalTrials.gov
• Defining the Ablative Dose for Y-90 TARE#834324ClinicalTrials.gov
• RFA for Treatment of Intermediate Stage HCC#836782ClinicalTrials.gov
• DKN-01 Inhibition in Advanced Liver Cancer#840995ClinicalTrials.gov
• Prospective Liver Tumor (ProLiT) Database#884011ClinicalTrials.gov
• 4th Generation Chimeric Antigen Receptor T Cells Targeting Glypican-3#888649ClinicalTrials.gov
• RFA Using Gradual RF Energy Delivery Mode With Octopus Electrodes#900569ClinicalTrials.gov
• Impact of C-arm CT in Patients With HCC Undergoing TACE: Optimal Imaging Guidance#910144ClinicalTrials.gov
• Optimization for Regorafenib in HCC#911847ClinicalTrials.gov
• A Phase IIa, Single-arm, Open-label Clinical Study to Evaluate the Efficacy, Safety and PK of CVM-1118 in Combination With Sintilimab and TACE in Participants With Incurable/Non-metastatic HCC#802260ClinicalTrials.gov
• A Study Evaluating Safety, Pharmacokinetics, Pharmacodynamics, And Clinical Activity Of RO7119929 (TLR7 Agonist) In Participants With Unresectable Advanced Or Metastatic Hepatocellular Carcinoma, Biliary Tract Cancer, Or Solid Tumors With Hepatic Metastases#885714ClinicalTrials.gov
• Study of Safety and Tolerability of PDR001 in Combination With Sorafenib and to Identify the Maximum Tolerated Dose and/or Phase 2 Dose for This Combination in Advanced Hepatocellular Patients#184867ClinicalTrials.gov
• Study of Pembrolizumab (MK-3475) as Monotherapy in Participants With Advanced Hepatocellular Carcinoma (MK-3475-224/KEYNOTE-224)#899129ClinicalTrials.gov
• Testing the Combination of the Anti-cancer Drugs XL184 (Cabozantinib) and Nivolumab in Patients With Advanced Cancer and HIV#426781ClinicalTrials.gov
• A Clinical-Radiomics Nomogram Predicts Early Tumor Necrosis After Transarterial Chemoembolization for Hepatocellular Carcinoma.#125392NCBI PubMed Central
• An XGBoost-Based Multicenter Model for Predicting HBV-Related Hepatocellular Carcinoma: Development and Validation.#135813NCBI PubMed Central
• Comprehensive Multi-Omics Characterization of CYP2R1 as a Diagnostic and Functional Biomarker in Hepatocellular Carcinoma.#135854NCBI PubMed Central
• Integrated Proteomics Reveal ALDH1A1 as an Oncogenic Driver and Regulatory Hub in Hepatocellular Carcinoma.#150054NCBI PubMed Central
• Nivolumab in Combination With TACE/TAE for Patients With Intermediate Stage HCC#152387ClinicalTrials.gov
• Phase II Study of PRL3-ZUMAB in Advanced Solid Tumors#201777ClinicalTrials.gov
• SR-HCC Score: A Novel Nomogram for Predicting Spontaneous Rupture in Hepatocellular Carcinoma Patients.#244272NCBI PubMed Central
• Roles of tumor associated neutrophils in the development of hepatocellular carcinoma and therapeutic implications.#258165NCBI PubMed Central
• Advanced liposomal nanoplatforms for flavonoid delivery: a mechanistic and comparative perspective in hepatocellular carcinoma.#297495NCBI PubMed Central
• Advances in liver transplantation for hepatic malignancies#311606Europe PMC
• National Translational Science Network of Precision-based Immunotherapy for Primary Liver Cancer#329506ClinicalTrials.gov
• The Clinical Significance of Peripheral Blood T Lymphocyte PD-1 Expression and T Cell Subset Distribution.#332766ClinicalTrials.gov
• Current pharmacological treatment of hepatocellular carcinoma#333015Dipòsit Digital de la Universitat de Barcelona
• Multi-omics identification of an antibody dependent cellular phagocytosis related signature for hepatocellular carcinoma.#368072NCBI PubMed Central
• Spatial architecture of tertiary lymphoid structures represents an independent prognostic dimension in hepatocellular carcinoma.#388839NCBI PubMed Central
• A putative hepatitis B virus sequence motif associated with hepatocellular carcinoma in South African adults#446719PubMed Central
• Liver reprogramming toward hepatocellular carcinoma following hepatitis C sustained virologic response: a narrative review.#452901NCBI PubMed Central
• CT-based HVPG Assessment for Predicting the Prognosis of HCC With TACE (CHANCE-CHESS 2302)#474856ClinicalTrials.gov